Ovarian cancer is laying?
Currently, the incidence rates of ovarian cancer accounts for gynecologic malignancy in 23% ~ 27% as the world's five largest high cancer mortality leapt gynecologic tumors in the first place. It can happen to women of any age, but occurred in the before and after menopause, about half occurred after the age of 65.
Because of the location of ovarian hidden in the pelvic cavity, in the event of early cancer, patients may have no symptoms, which was not to attract attention, not easy to take the initiative to conduct inspections, often found to have advanced, it is very difficult to treatment. Therefore, patients with ovarian cancer five-year survival rate of only 30% to 50%. If women above 30 years of age, especially after menopause in women, and to have regular gynecological pelvic ultrasound examination can be early detection, early diagnosis, timely and reasonable treatment, ovarian cancer five-year survival rate can reach 90%.
Treatment of ovarian cancer is the main means of surgical resection and postoperative chemotherapy is also very important, but also with immunotherapy, radiotherapy, hormone therapy and Chinese medicine treatment. The quality of the treatment effect and survival depends on the length of the complete tumor resection. Therefore, surgery should maximize the removal of the tumor lesion. For those small tumors and the naked eye to see the residual tumor cells after chemotherapy must take.
Currently, ovarian cancer after chemotherapy used early, adequate, multi-course approach, which is to improve the cure rate and prolong survival time in the best option. Because of the proliferation of ovarian cancer metastasis approach to the pelvic widely planted mainly, to make tumors more exposed to the drug, ovarian cancer chemotherapy frequently used methods of intraperitoneal administration. Radiotherapy treatment of ovarian cancer is a complementary therapy, mainly for certain chemotherapy ineffective. Chinese medicine to improve patient immunity of the body has a good role. Immunotherapy, gene therapy, although some effect, but have not yet applied to the large clinical.
Tags: administration, age, body, cancer, cause, cell, cells, chemotherapy, clinical, diagnosis, drug, early, eat, ert, examination, gene, gynecological, incidence, intraperitoneal, life, metastasis, method, ovarian, patients, pelvic, quality, radiotherapy, rate, resection, residual, surgery, surgical, survival, symptoms, therapy, time, treatment, tumor, tumors, women